Hims & Hers Health Inc Stock Price, News & Analysis

Hims & Hers Health has unveiled attractive holiday bundles featuring discounts on popular hair and skin products. Consumers can enjoy up to 30% off original prices, with products like the Hims Hair Gift Set priced at $39.90 and the Hers Hair Gift Set at $44.10. The Hims Skin Gift Set is available for $52.50. Additional offerings include a cologne available at 50% off. This initiative aims to meet customer demand for gifting options during the holiday season.

Hims & Hers Health, Inc. (NYSE: HIMS) is expanding its market reach by launching an official store on Amazon. This new initiative aims to enhance product accessibility, offering a range of health and wellness products including supplements and sexual health items. CEO Andrew Dudum stated this move addresses increasing consumer demand and allows the company to connect with digitally savvy customers. Exclusive bundles will also be available, including popular personal care products. This development reflects Hims & Hers' strategy to broaden its customer base and capitalize on retail opportunities.

Hims & Hers Health has announced the launch of its new mobile app aimed at providing personalized health services to over 500,000 subscribers. The app will feature curated health programs, 24/7 concierge services, and access to both medical experts and a specially designed Member Store for health products. CEO Andrew Dudum emphasized the app as a pivotal step in reshaping healthcare access, promising to streamline the user experience akin to popular platforms like Spotify and Netflix. The app will be available on both iOS and Android in the coming weeks.

Hims & Hers Health reported a 79% year-over-year revenue increase for Q3 2021, totaling $74.2 million, surpassing guidance. The company achieved 551,000 member subscriptions, a 95% increase from the previous year. Despite strong growth, the net loss widened to $(15.9) million, compared to $(5.9) million in Q3 2020, and Adjusted EBITDA remained negative at $(9.8) million. The company expects revenue for Q4 2021 between $76 million and $78 million and a full-year revenue forecast of $263 million to $265 million.

Hims & Hers Health, Inc. (NYSE:HIMS) announced participation in the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021. CEO Andrew Dudum and Chief Medical Officer Patrick Carroll will hold one-on-one meetings and a live webcast of Dudum's fireside chat is scheduled for 4:20 PM ET. The webcast will be accessible on Hims & Hers investor relations website and archived for 90 days. The company, founded in November 2017, offers a multi-specialty telehealth platform providing access to healthcare for various conditions across the U.S.

Hims & Hers (NYSE: HIMS) and Walgreens (NASDAQ: WBA) have announced a collaboration to enhance access to health and wellness solutions. Hims & Hers products, including supplements and sexual health offerings, will be available at over 7,000 Walgreens locations and on walgreens.com starting early November. This partnership aims to destigmatize health topics and support Hims & Hers' goal of mass market accessibility, providing trusted health products to consumers in the U.S.

Hims & Hers has launched the Climax Delay Wipes, a non-prescription treatment aimed at addressing premature ejaculation, which affects nearly 1 in 4 men. These single-use benzocaine wipes are designed to help men maintain erections and gain better control over their climax. This addition complements existing products like Climax Delay Spray and various prescription options available through telehealth consultations. CEO Andrew Dudum emphasized the company's mission to enhance personalized healthcare access, providing a range of solutions for sexual health.

Hims & Hers Health, a telehealth platform, will release its fiscal third quarter financial results on November 10, 2021, after the market closes. A conference call is scheduled for 5:00 p.m. E.T. The company connects consumers to healthcare professionals for a variety of medical concerns, including primary care and mental health. Hims & Hers operates across all 50 states and Washington, D.C., providing accessible healthcare solutions. Investors and media are invited to access the live call or listen to a replay online.

Regis Corporation (NYSE:RGS) announces John Davi as the new Chief Technology Officer, aiming to enhance its Opensalon ecosystem. With over 20 years in technology, Davi has previously worked with BriteCore and MINDBODY, and has experience in artificial intelligence and media solutions. His expertise is expected to drive technology development and improve franchisee support. Regis operates the world's largest franchise network of hair salons, with 5,917 locations globally as of June 30, 2021.